MCID: BRS047

Summaries for Breast Cancer

Sources:
6Disease Ontology, 23MedlinePlus, 2CDC, 17Genetics Home Reference, 44Wikipedia, 33OMIM, 22MalaCards
See all sources

Export this MalaCard
MedlinePlus: Breast cancer affects one in eight women during their lives. breast cancer kills more women in the united states than any cancer except lung cancer. no one knows why some women get breast cancer, but there are a number of risk factors. risks that you cannot change include age - the chance of getting breast cancer rises as a woman gets older genes - there are two genes, brca1 and brca2, that greatly increase the risk. women who have family members with breast or ovarian cancer may wish to be tested. personal factors - beginning periods before age 12 or going through menopause after age 55 other risks include being overweight, using hormone replacement therapy (also called menopausal hormone therapy), taking birth control pills, drinking alcohol, not having children or having your first child after age 35 or having dense breasts. symptoms of breast cancer may include a lump in the breast, a change in size or shape of the breast or discharge from a nipple. breast self-exam and mammography can help find breast cancer early when it is most treatable. treatment may consist of radiation, lumpectomy, mastectomy, chemotherapy and hormone therapy. men can have breast cancer, too, but the number of cases is small. nih: national cancer institute23

MalaCards: Breast Cancer, also known as malignant neoplasm of breast, is related to carcinoma and prostatitis. An important gene associated with Breast Cancer is BCAR3 (breast cancer anti-estrogen resistance 3), and among its related pathways are Metabolic pathways and Akt Signaling. The drugs ifosfamide and vinorelbine and the compounds atp and progesterone have been mentioned in the context of this disorder. Affiliated tissues include bone marrow, whole blood and lymph node, and related mouse phenotypes are homeostasis/metabolism and cellular.

Disease Ontology: A thoracic cancer that originates in the mammary gland.6

CDC: In the United States in 2008,* 210,203 women were diagnosed with breast cancer, and 40,589 women died from the disease.† Except for skin cancer, breast cancer is the most common cancer among American women. CDC supports breast cancer surveillance and research, and provides free or low-cost mammograms to underserved women.2

Genetics Home Reference: Breast cancer is a disease in which certain cells in the breast become abnormal and multiply without control or order to form a tumor. The most common form of breast cancer begins in cells lining the ducts that carry milk to the nipple (ductal cancer). Other forms of breast cancer begin in the glands that produce milk (lobular cancer) or in other parts of the breast.17

Wikipedia: Breast cancer is a type of cancer originating from breast tissue, most commonly from the inner lining of...44 more...

OMIM: 114480

Aliases & Descriptions for Breast Cancer

Sources:
6Disease Ontology, 7diseasecard, 44Wikipedia, 17Genetics Home Reference, 8DISEASES, 33OMIM, 32Novoseek , 23MedlinePlus, 2CDC, 43UMLS, 40SNOMED-CT, 27NCIt, 24MeSH
See all sources

Aliases & Descriptions:

breast cancer 6 7 44 17 8 33 32 23
malignant neoplasm of breast 6 44 17
mammary cancer 6 44 17
malignant tumor of breast 44 17
male breast cancer 44 17
cancer of breast 44 17
mammary tumor 6 32
malignant tumor of the breast 6
primary malignant neoplasm 43
animal mammary neoplasms 43
carcinoma of male breast 43
primary breast cancer 6
malignant neoplasms 43
mammary neoplasms 43
breast carcinoma 43
ca breast - nos 6
breast tumor 6

Related Diseases for Breast Cancer

Sources:
13GeneCards, 14GeneDecks
See all sources

Disease types for breast cancer family:

breast cancer, type 3

Diseases related to breast cancer by text searches and GeneDecks gene sharing:

(show top 50)    (show all 1114)
idRelated DiseaseScoreTop Affiliating Genes
1carcinoma500.4ZNF673, ZNF217, PIK3CB, PIP, PIK3CD, PIK3CA
2prostatitis500.4ZNF673, PIK3CB, PIP, PIK3CD, PIK3CA, PIK3R3
3leukemia499.1ZNF673, PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2
4pancreatitis496.0PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
5neuronitis495.3PIK3CB, PIK3CD, PIK3CA, PIK3R3, PINK1, PIK3R2
6adenocarcinoma494.0ZNF217, PIK3CB, PIP, PIK3CA, PIK3R1, PIK3C2A
7colorectal cancer464.9ZNF217, ZNF668, PIK3CB, PIK3CD, PIK3CA, PIK3R3
8hepatocellular carcinoma428.6PIK3CB, PIK3CD, PIK3CA, PIK3R1, PIK3CG, PIN1
9melanoma428.3PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
10thyroiditis414.8ZNF331, PIK3CB, PIK3CA, PIP5K1C, PIK3R1, PIK3C2A
11gastric cancer398.2PIK3CB, PIK3CA, PIK3R1, PIK3CG, PIN1, PINX1
12breast carcinoma364.5ZNF217, PIP, PIK3CA, PIK3R1, PIK3CG, LRP1
13colon cancer354.8PIK3CB, PIK3CA, PIK3R3, PIK3R1, PIK3CG, LRRC26
14hypoxia343.7ZNF217, PIK3CB, PIK3CD, PIK3CA, PIK3R1, PIK3C2A
15cervicitis341.0ZNF350, ZNF217, PIK3CA, PIK3CG, PIN1, LRIG1
16alzheimer's disease312.3ZNF365, PIK3CB, PIK3CD, PIK3CA, PINK1, PIK3R1
17arthritis310.1PIK3CD, PIK3CG, PIN1, LRP1, LRP5, KL
18neuroblastoma307.1PIK3CB, PIK3CD, PIK3CA, PIK3R1, PIK3CG, PIN1
19sarcoma295.4PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIK3R1, PIK3C2A
20rheumatoid arthritis286.5PIK3CD, PIK3CG, PIN1, LRP1, LRP5, KL
21cholesterol285.5PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIK3R1, PIK3C2A
22adenoma283.9ZNF331, PIK3CA, KLF4, NCAM1, NCF2, NCOA1
23myeloid leukemia277.8ZNF673, PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2
24fibrosis271.8PIK3CA, PIAS3, PIK3CG, PIN1, LRP1, KL
25myeloma264.2PIK3CA, PIAS3, PIK3R2, PIK3R1, PIK3CG, LRP1
26retinitis263.2PIK3CA, PIK3C2A, PIK3CG, LRAT, LRP1, LRP5
27ovarian carcinoma260.8PIP, PIK3CA, PIP5K1C, PIP5K1A, PIK3CG, NCOA3
28hepatitis b248.6PIK3CA, PIK3R1, PIK3C2A, PIK3CG, PIN1, KLF6
29lung carcinoma237.2PIK3CA, PIK3R1, PIK3CG, KLF6, NCAM1, RECK
30cervical cancer236.1ZNF350, ZNF217, PIK3CA, PIK3CG, PIN1, LRIG1
31atherosclerosis235.0ZNF673, PIK3C2A, PIK3CG, LRP1, LRP5, LRP6
32hypertension234.0PIK3CB, PIK3R1, PIK3C2A, PIK3CG, LRP1, LRP5
33obesity226.3PIK3CB, PIK3CA, PIK3R1, PIK3C2A, PIK3CG, LRP1
34colon carcinoma224.4PIK3CB, PIK3CA, PIK3R2, PIK3R1, PIK3CG, KL
35esophagitis222.3ZNF673, PIK3CB, PIK3CA, PIK3C2A, PIK3CG, PIN1
36ischemia220.9PIK3CA, PIK3C2A, PIK3CG, COG2, KLF4, NDFIP1
37lymphocytic leukemia219.7PIK3CD, PIK3CA, PIK3CG, NCAM1, NCL, PDE4A
38osteosarcoma216.4PIK3CB, PIK3CA, PIK3CG, LRP5, KLF10, RFC1
39multiple myeloma215.3PIK3CA, PIAS3, PIK3R2, PIK3R1, PIK3CG, LRP1
40astrocytoma208.5PIK3CA, PIK3R1, PIK3CG, LRP1, KLF6, NCAM1
41prostate carcinoma204.0PIP, PIAS3, PIK3R1, PIK3CG, LRP1, KLF6
42acute myeloid leukemia201.5ZNF673, PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2
43lymphoblastic leukemia198.4PIK3CA, PIK3CG, LRP5, SH2D4B, COG2, KLF10
44lupus erythematosus196.7PIK3CD, PIK3C2A, PIK3CG, COG2, NCF2, NCL
45gonococcal synovitis194.4PIK3CB, PIK3CA, PIK3R1, PIK3CG, LRP1, KLF4
46endometrial cancer193.5PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
47anemia191.5ZNF276, NDFIP1, RFX1, NCAM1, NCOR1, PDCD1
48retinoblastoma186.2PIK3CB, PIK3CD, PIK3CA, PIK3R1, PIK3CG, KLF6
49epithelial ovarian cancer182.3PIK3CB, PIK3CA, PIK3R3, PIK3CG, NCOA1, NCOA3
50myocardial infarction172.0PIK3C2A, PIK3CG, LRP1, COG2, KLF10, PDCD1

Graphical network of the top 20 diseases related to breast cancer:



Graphical network of diseases related to breast cancer

Clinical Features for Breast Cancer

Sources:
33OMIM
See all sources
Clinical features from OMIM: 114480

Drugs & Therapeutics for Breast Cancer

Sources:
4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT
See all sources

Genetic Tests for Breast Cancer

Anatomical Context for Breast Cancer

Sources:
22MalaCards
See all sources

MalaCards organs/tissues related to breast cancer:

22
Bone marrow, Whole blood, Lymph node, Spleen, Thymus, Brain, Cortex, Spinal cord, Heart, Smooth muscle, Skeletal muscle, Small intestine, Colon, Adipocyte, Kidney, Liver, Lung, Pancreas, Thyroid, Salivary gland, Adrenal gland, Breast, Skin, Ovary, Uterus, Placenta, Prostate, Testis, Cervix, Myeloid, Monocytes, Nk cells, T cells, B lymphoblasts, B cells, Endothelial, Fetal brain, Pons, Fetal liver, Fetal lung, Fetal thyroid, Adrenal cortex, Pineal, Pituitary, Uterus corpus, Testis germ

Phenotypes for genes affiliated with Breast Cancer

Sources:
25MGI
See all sources

MGI Mouse Phenotypes related to breast cancer:

25 (show all 29)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1homeostasis/metabolism phenotypeMP:0005376280.5PIK3CB, PIK3CD, PIP4K2B, PIK3CA, PINK1, PIK3R2
2cellular phenotypeMP:0005384278.8PIK3CB, PIK3CD, PIK3CA, PINK1, PIP5K1C, PIK3R1
3mortality/agingMP:0010768278.5PIK3CB, PIP4K2B, PIK3CA, PIP5K1C, PIP5K1A, PIK3C2A
4growth/size phenotypeMP:0005378243.8PIK3CB, PIP4K2B, PIK3CA, PINK1, PIP5K1C, PIK3R1
5cardiovascular system phenotypeMP:0005385196.2PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIP5K1C, PIK3R1
6immune system phenotypeMP:0005387176.5PIK3CD, PINK1, PIP5K1C, LRP1, LRP5, SH2D3C
7nervous system phenotypeMP:0003631167.1PIP5K1C, PICK1, LRIG1, LRAT, LRP1, LRP5
8behavior/neurological phenotypeMP:0005386161.8PIK3CA, PINK1, PIP5K1C, LRP1, LRP5, LRP6
9hematopoietic system phenotypeMP:0005397139.4PIP5K1C, PIP5K1A, PINX1, SH2D3C, KLF6, NDFIP1
10reproductive system phenotypeMP:0005389134.5PIK3CA, PIP5K1A, PICK1, LRAT, LRP6, SH2D3C
11integument phenotypeMP:0010771133.0PIK3CG, PIN1, PINX1, LRIG1, LRP6, KL
12normal phenotypeMP:0002873131.6PIK3R1, PIP5K1A, LRIG1, LRP1, LRP5, LRP6
13embryogenesis phenotypeMP:0005380130.1PIK3CB, PIK3CA, PIP5K1C, PINX1, LRP5, LRP6
14tumorigenesisMP:0002006121.3PIK3CB, PIK3CA, PIK3R2, PIK3R1, PINX1, LRIG1
15muscle phenotypeMP:0005369118.5PIK3CA, PIK3R2, PIK3R1, PIK3CG, LRP1, KL
16digestive/alimentary phenotypeMP:0005381117.7LRIG1, LRP6, KL, KLF4, KLF5, NCOA3
17vision/eye phenotypeMP:0005391108.4PIK3CA, PIN1, LRAT, LRP5, LRP6, NCAM1
18skeleton phenotypeMP:000539093.4PIK3CD, PIK3CG, LRP1, LRP6, KLF10, NCOA1
19renal/urinary system phenotypeMP:000536787.9LRP6, KL, NCK1, NCOA1, NCOA3, PDCD1
20no phenotypic analysisMP:000301278.2PIK3CD, PINK1, PIK3R1, LRP6, SH2D3C, COBRA1
21liver/biliary system phenotypeMP:000537076.7LRP5, LRP6, KLF6, NDFIP1, NCOA3, NCOA6
22endocrine/exocrine gland phenotypeMP:000537974.6PINK1, PIP5K1A, PICK1, LRIG1, LRP5, KL
23limbs/digits/tail phenotypeMP:000537172.6PIP4K2B, LRIG1, LRP5, LRP6, KL, KLF10
24craniofacial phenotypeMP:000538269.7LRIG1, LRP5, LRP6, KLF4, NCOA3, NCOA6
25adipose tissue phenotypeMP:000537565.0PIP4K2B, PIK3CA, PIK3R1, PIK3C2A, LRP1, LRP6
26hearing/vestibular/ear phenotypeMP:000537756.2LRP6, NCOA3, KIT, KITLG, RDX, SFN
27respiratory system phenotypeMP:000538855.1LRP6, KL, KLF5, NDFIP1, REL, RELB
28pigmentation phenotypeMP:000118640.2LRP5, NCOA6, RECQL4, KIT, KITLG, PCBD1
29other phenotypeMP:000539533.7KL, RECK, RELB, CNR1, VPS35, BUB1

Publications for genes affiliated with Breast Cancer

Sources:
35PubMed
See all sources

Articles related to breast cancer:

(show top 50)    (show all 16611)
idTitleAuthorsYearAffiliating Genes
1Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. (21876083)Cybulski C.... LubiA8ski J.2011CHEK2
2ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells. (20661224)Krig S.R.... Sweeney C.A.2010ERBB3, ZNF217
3Multidrug resistance in breast cancer cells during ep ithelial-mesenchymal transition is modulated by breast cancer resistant protein . (20109342)Chen W.J.... Li W.T.2010ABCG2
4Identification of a functional genetic variant at 16q 12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium. (20585626)Long J.... Zheng W.2010TOX3
5Interaction between ADH1C Arg(272)Gln and alcohol int ake in relation to breast cancer risk suggests that ethanol is the causal facto r in alcohol related breast cancer. (20350778)Benzon Larsen S.... Tolstrup J.2010ADH1C
6Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance. (19075277)van Agthoven T.... Dorssers L.C.2009AKT2, SRC, AKT1
7Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. (19190326)Hurst D.R.... Welch D.R.2009MIR146A, MIR146B
8Controversies in breast cancer: the mammalian target of rapamycin as a target for breast cancer therapy. (20030877)Di Cosimo S.2009AKT1, PIK3CG, MTOR
9Rac1 contributes to trastuzumab resistance of breast cancer cells: Rac1 as a potential therapeutic target for the treatment of trast uzumab-resistant breast cancer. (19509242)Dokmanovic M.... Wu W.J.2009ERBB2, EGFR, RAC1
10Androgen-induced human breast cancer cell proliferati on is mediated by discrete mechanisms in estrogen receptor-alpha-positive and - negative breast cancer cells. (19159686)Lin H.Y.... Davis P.J.2009ESR1
11DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study. (18463976)Tao M.H.... Freudenheim J.L.2009CDH1, CDKN2A
12Breast cancer low-penetrance allele 1100delC in the CHEK2 gene: Not present in the Chinese familial breast cancer population. (18484200)Chen W.... Liansheng N.2008CHEK2
13Hereditary breast cancer: part II. Management of here ditary breast cancer: implications of molecular genetics and pathology. (18086271)Silva E.... Lynch H.T.2008BRCA1, BRCA2
14Her-2/neu amplification and breast cancer survival: results from the Shanghai breast cancer study. (18425397)Beeghly-Fadiel A.... Zheng W.2008ERBB2
15Molecular detection of disseminated breast cancer cells in the bone marrow of early breast cancer patients using quantitative RT PCR for CEA. (18505343)Janku F.... Hajduch M.2008CEACAM5
16Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling. (17616674)Schrecengost R.S.... Bouton A.H.2007BCAR1, BCAR3
17A comparative study of Korean with Caucasian breast cancer reveals frequency of methylation in multiple genes correlates with breast cancer in young, ER, PR-negative breast cancer in Korean women. (17611401)Lee J.S.... Sukumar S.2007GSTP1, RARB, CCND2
18Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer. (17640394)Howe L.R.2007PTGS2
19BEX2 is overexpressed in a subset of primary breast cancers and mediates nerve growth factor/nuclear factor-kappaB inhibition of apoptosis in breast cancer cell lines. (17638883)Naderi A.... Caldas C.2007NFKB1, NGFR, NGF
20BARD1 variants are not associated with breast cancer risk in Australian familial breast cancer. (17972171)Gorringe K.L.... Campbell I.G.2007BARD1
21Alternative splicing of breast cancer associated gene BRCA1 from breast cancer cell line. (17244477)Lixia M.... Congyi Z.2007BRCA1
22Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion. (17130833)Mehta S.A.... Nakshatri H.2007CXCR4, TP53, JUN
23Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer. (16319991)Brewster A.M.... Helzlsouer K.J.2006ERCC2, XRCC1
24Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry. (16958054)Bernstein J.L.... Concannon P.2006ATM
25Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in subsets of breast cancer patients. (17121889)Hicks D.G.... Casey G.2006ERBB2
26Energy balance adiposity and breast cancer - energy restriction strategies for breast cancer prevention. (16436101)Harvie M.... Howell A.2006IL6, ADIPOQ
27Regulatory mechanisms for abnormal expression of the human breast cancer specific gene 1 in breast cancer cells. (16989287)Lu A.... Liu J.2006SNCG
28Phosphorylation of ERalpha at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERalpha phosphorylation in breast cancer progression. (16954434)Sarwar N.... Ali S.2006ESR1
29Lack of an effect of breast cancer resistance protein (BCRP/ABCG2) overexpression on methotrexate polyglutamate export and folate accumulation in a human breast cancer cell line. (15588721)Rhee M.S.... Schneider E.2005ABCG2
30CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study. (15987458)Chang J.H.... Spurdle A.B.2005CYP17A1
31The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'. (14760111)Atalay G.... Paridaens R.2004CYP19A1
32Extracellular DNA in breast cancer: Cell-surface-bound, tumor-derived extracellular DNA in blood of patients with breast cancer and nonmalignant tumors. (15251963)Rykova E.Y.... Vlassov V.V.2004RASSF1, HIC1
33Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer. (15030120)Taucher S.... Jakesz R.2004ERBB2
34CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors. (12631398)Ambrosone C.B.... Shields P.G.2003CYP17A1
35Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer. (12554765)Cui X.... Lee A.V.2003PGR, IGF1
36Expression of the breast cancer resistance protein in breast cancer. (11948115)Faneyte I.F.... van de Vijver M.J.2002ABCG2
37Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. (11911959)Laud K.... Djiane J.2002LEPR
38CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk. (11857408)Lei H.... Vorechovsky I.2002CDH1
39Detection of VIP receptors in MNU-induced breast cancer in rats: implications for breast cancer targeting. (11245339)Dagar S.... Onyuksel H.2001VIPR1, VIP, SCT
40Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. (10029072)Hardwick M.... Papadopoulos V.1999TSPO
41Vorozole (R83842) in the treatment of postmenopausal advanced breast cancer: relationship of serum levels of vorozole and clinical r esults (a study of the EORTC Breast Cancer Cooperative Group). (9660539)Bruning P.F.... Piccart M.J.1998CYP19A1
42Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III random ized trial. Australian-New Zealand Breast Cancer Trials Group. (9294477)Byrne M.J.... Stewart J.1997PGR
43Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium. (9167459)1997BRCA1, BRCA2
44Increased thromboembolic complications with concurren t tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for wome n with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group. (8874334)Pritchard K.I.... Pater J.1996PGR, ESR1
45The T61 human breast cancer xenograft: an experimental model of estrogen therapy of breast cancer. (8738608)Brunner N.... Cullen K.1996IGF1R, ESR1, IGF2
46Expression of BCL-2 in primary breast cancer and its correlation with tumour phenotype. For the International (Ludwig) Breast Cancer Study Group. (7915536)Nathan B.... Gelber R.1994BCL2
47Immunocytochemical determination of the estrogen-regu lated proteins Mr 24,000, Mr 52,000 and DF3 breast cancer associated antigen: c linical value in advanced breast cancer and correlation with estrogen receptor. (1606073)Damstrup L.... Poulsen H.S.1992MUC1
48Relative effect of steroid hormone receptors on the prognosis of patients with operable breast cancer. A univariate and multivariate analysis of 3089 Japanese patients with breast cancer from the Study Group for the Japanese Breast Cancer Society on Hormone Receptors and Prognosis in Breast Cancer. (1727658)Nomura Y.... Morimoto T.1992PGR
49Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. The Breast Cancer Study Group. (1854977)Koenders P.G.... Benraad T.J.1991ESR1
50Evaluation of the predictive power of progesterone receptor levels in primary breast cancer: a comparison with other criteria in 559 cases with a mean follow-up of 74.8 months. The Breast Cancer Prognostic Study Associates. (2228719)Huseby R.A.... Russo J.1990PGR

Expression for genes affiliated with Breast Cancer

Sources:
1BioGPS
See all sources
Expression patterns in normal tissues for genes affiliated with Breast Cancer

Pathways for genes affiliated with Breast Cancer

Sources:
20KEGG, 36QIAGEN, 3Cell Signaling Technology, 37R&D Systems, 41Thomson Reuters, 10EMD Millipore, 38Reactome
See all sources

Pathways related to breast cancer according to GeneDecks:

(show top 50)    (show all 480)
idPathwayScoreTop Affiliating Genes
1Metabolic pathways2067.4PIP5K1C, PIP5K1A, PIGT, PIK3C2A, COASY, KL
2Akt Signaling3647.1PIP, PIK3R3, PIK3R4, PIK3R1, PIK3CG, KIT
3Transendothelial Migration of Leukocytes3639.2PIK3R3, PIK3R2, PIK3R4, PIK3R1, NCF2, NCF4
4Activation of cAMP-Dependent PKA3638.7KITLG, BTC, SEMA3A, SEMA4B, SEMA5A, SEMA4G
5PTEN Pathway3637.9PIK3R3, PIK3R2, PIK3R4, PIK3R1, KIT, KITLG
6Focal adhesion2034.3PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIP5K1C
7Cytoskeletal Signaling332.9NCK1, REPS1, WASF2, WASF3, WASL, RDX
8TGF-beta Signaling Pathways3730.7PIK3CB, PIK3CD, PIK3R2, PIK3R1, PIK3CG, NCOR1
9Osteoclast differentiation2030.7PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
10Colorectal Cancer Metastasis3629.7PIK3R3, PIK3R2, PIK3R4, PIK3R1, LRP5, LRP6
11Measles2028.9PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
12Hepatitis C2028.7PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIAS3, PIK3R2
13Wnt / Hedgehog / Notch324.9LRP5, LRP6, KLF4, NCSTN, SFRP1, RBPJ
14p53 Signaling3624.1SFN, BRCA1, BCL2, CHEK1, CHEK2, UBB
15TRAF Pathway3623.5PIK3R3, PIK3R2, PIK3R4, PIK3R1, BIRC2, BIRC3
16Actin Nucleation by ARP-WASP Complex3623.2NCK1, WASF1, WASL, KIT, LMTK2, LMTK3
17IL-2 Pathway3622.8PIK3R3, PIK3R2, PIK3R4, PIK3R1, MYC, RAF1
18IGF1R Signaling3622.6PIK3R3, PIK3R2, PIK3R4, PIK3R1, BRAF, RAF1
19Translation_Non-genomic (rapid) action of Androgen Receptor4121.9PIK3CA, PIK3R1, REL, RELA, RELB, RAF1
20Development Flt3 signaling1021.7PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIK3R1, VAV1
21Cell adhesion_ECM remodeling4121.2VTN, SERPINE2, SERPINE1, VCAN, SDC2, LAMA3
22Development FGFR signaling pathway1020.7PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
23G-AlphaQ Signaling3620.3PIK3R3, PIK3R2, PIK3R4, PIK3R1, BRAF, RAF1
24Development_Flt3 signaling4120.2PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIK3R1, VAV1
25Apoptosis and survival_TNFR1 signaling pathway4119.8REL, RELA, RELB, BID, BIRC2, BIRC3
26Bladder cancer2019.7RB1, BRAF, VEGFA, VEGFB, VEGFC, MYC
27Signaling by EGFR3819.6PIK3CD, KL, BTC, MTOR, CD86, CD80
28Development_Ligand-independent activation of ESR1 and ESR24119.6PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
29Immune response_CD28 signaling4119.5PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIP5K1C
30RANK Signaling in Osteoclasts3619.4PIK3R3, PIK3R2, PIK3R4, PIK3R1, BRAF, RAF1
31Apoptotic Pathways Triggered By HIV13619.3BID, BIRC2, BIRC3, BCL2, BCL2L1, CHUK
32SUMO Pathway3619.2RANBP1, RAN, CHUK, UBE2I, ATF4, MRAS
33Development_GDNF family signaling4119.0PIK3CB, PIK3CA, PIK3R2, PIK3R1, NCK1, RELA
34Cell adhesion PLAU signaling1018.7PIK3CB, PIK3CD, PIK3CA, PIK3R3, PIK3R2, PIK3R1
35Development_A2B receptor- action via G-protein alpha s4118.6PIK3CB, PIK3CD, PIK3CA, REL, RELA, RELB
36BAD Phosphorylation3618.4PIK3CD, PIK3R3, RAF1, BCL2, BCL2L1, YWHAE
37Transcription PPAR Pathway1018.3PIK3CB, PIK3CD, PIK3CA, PIK3R2, PIK3R1, NCOA1
38CRHR Pathway3618.1CNR1, BRAF, VEGFC, RAP1A, RAF1, UTS2
39CNTF Signaling3618.0PIK3R3, PIK3R2, PIK3R4, PIK3R1, CNTF, RAF1
40Alzheimers Disease Pathway3617.9LRP1, LIFR, BACE2, CDK5, CDK5R1, INSR
41Development_Growth hormone signaling via PI3K/AKT and MAPK cascades4117.8PIK3R1, CEBPB, ATF2, JUN, JUNB, JAK2
42NF-KappaB Activation by EBV3617.6PIK3R3, PIK3R2, PIK3R4, PIK3R1, CHUK, ATF2
43NF-kappaB Activation by Viruses3617.3PIK3R3, PIK3R2, PIK3R4, PIK3R1, RELA, BRAF
44IL-1 Pathway3615.9CHUK, JUN, IRAK3, IL1A, IL1B, IL1R1
45Inhibitory action of Lipoxins and Resolvin E1 on neutrophil functions4115.3PIK3CG, REL, RELA, RELB, CHUK, CFTR
46fMLP Pathway3615.3PIK3R3, PIK3R2, PIK3R4, PIK3R1, RAC3, RAF1
47Long-term potentiation2013.9BRAF, RAP1A, RAF1, ATF4, ITPR1, ITPR2
48Immune response_ICOS pathway in T-helper cell4113.0PIK3CB, PIK3CD, PIK3CA, PIK3CG, REL, CD3D
49Inhibitory action of Lipoxins on Superoxide production in neutrophils4112.3PIK3CG, NCF2, NCF4, RAC2, PAK1, ITPR1
50Development EGFR signaling pathway1011.8BTC, CBL, EREG, NFKBIE

Compounds for genes affiliated with Breast Cancer

Sources:
32Novoseek , 42Tocris Bioscience, 9DrugBank, 18HMDB, 34PharmGKB
See all sources

Compounds related to breast cancer according to GeneDecks:

(show top 50)    (show all 413)
idCompoundScoreTop Affiliating Genes
1atp32 122.9PIK3CB, PIK3CA, PINK1, PIK3C2A, LRAT, RFC1
2progesterone32 42 9 18 9 102.5PIP, PIK3CA, PIK3R1, LRAT, NCAM1, NCOA1
3cholesterol32 9 18 9 99.3PIK3CB, PIK3CA, PIK3R1, PIK3C2A, LRAT, LRP1
4glucose32 69.2PDE4A, SGK3, CNTF, KIT, KISS1, PCSK2
5pge232 56.2PDE4A, SGCB, CNTF, VTN, SELE, SETD2
612-o-tetradecanoylphorbol 13-acetate32 55.2NCAM1, RET, CNTF, RB1, SERPINB2, BRAF
7gtp32 52.4PIK3CA, PIK3R1, PIK3C2A, NCF2, RECK, RERG
8norepinephrine32 9 18 9 51.7PIK3C2A, PDE4A, RETN, CNR1, CNTF, KITLG
95-aza-2deoxycytidine32 45.1KITLG, SFRP1, PCNA, RBP1, SERPINB5, SEMA3B
10ascorbic acid32 18 45.7PIK3CG, SGCB, CNTF, PCNA, RBP4, SETD2
11imatinib32 34 9 9 46.5PIK3CA, PIK3R1, PIK3CG, RET, KIT, KITLG
12resveratrol32 9 18 9 42.7PIK3CA, PIK3CG, PCNA, RB1, BSG, BRCA1
13bromodeoxyuridine32 36.0PIK3CA, PIK3R1, NCAM1, NCOA3, CNTF, KITLG
14sucrose32 9 18 9 35.7LRP1, RECK, PCSK2, RBP4, BSG, VCL
15gf 109203x32 42 33.0PIK3CB, PIK3CG, KITLG, VEGFA, VCL, RAP1A
16sterol32 31.4PIK3R1, LRP1, COG2, RETN, GC, RBP1
17gaba32 42 31.6NCAM1, RELN, CNR1, CNTF, VIM, VIP
18suramin32 9 9 30.9LRP1, NCAM1, RECK, PCNA, VIP, VEGFA
19pdtc32 28.3PIK3CA, PIK3CG, SELE, SETD2, SERPINB5, VCAM1
20bortezomib32 9 9 29.6SETD2, BRCA1, VEGFA, VCP, MYC, BID
2115-deoxy-delta-12,14-prostaglandin j232 27.5PIK3CG, SERPINE1, VEGFA, VCAM1, MYC, BMP6
22atorvastatin32 34 9 18 9 31.1PIK3C2A, COG2, RETN, VWF, SELE, SELP
234-hydroxynonenal32 18 27.9MYC, MYB, PARP1, CHKA, CHUK, LCAT
24egcg32 25.5PIK3CG, RAF1, BCL2L1, CHUK, UGT1A, UGT1A1
25trastuzumab32 34 9 9 27.2PIK3CA, PIK3R1, PIK3CG, KIT, VEGFC, RAF1
26morphine32 9 9 26.0CNR1, VIP, KCNJ5, UGT1A, UGT1A1, UGT1A6
27dbc-amp32 23.8LRP1, NCAM1, PDE4A, VIM, VIP, NAGLU
28progestins32 23.7PIP, SERPINA7, SERPINA6, LIF, PAEP, S100A6
29tunicamycin32 23.3PIK3CG, RECK, LPL, CLU, PARK2, BDNF
30salicylic acid32 23.1PIK3CG, CNR1, SERPINA7, SERPINA1, LPO, VDR
31uric acid32 18 23.5PIK3C2A, RETN, RBP4, SERPINE1, NAGLU, LPA
32n-(4-hydroxyphenyl)retinamide32 22.4RB1, RBP4, RBP1, VIM, MYC, BMP6
33sorafenib32 9 9 24.2RET, KIT, BRAF, VHL, VEGFA, RAF1
34hydroxyapatite32 22.0KITLG, VTN, VIM, VCL, BMP2, BMP3
35neopterin32 21.9NAGLU, LGALS3BP, CHKB, LCN2, LBR, B2M
36leptomycin b32 21.9BRCA1, RANBP1, RAN, LIMK1, LIMK2, BIRC5
37colchicine32 9 9 23.1PIK3C2A, VIM, NAGLU, BRCA1, VCL, CLU
38thromboxane a232 18 22.1PIK3C2A, PDE4A, VWF, SELP, NAGLU, LIF
39ganciclovir32 9 9 22.6KITLG, VIM, BMP6, KDR, LEP, CEACAM3
40tcdd32 20.4NCOR2, SERPINB2, RAG1, RARS, PAX5, UROD
41dutp32 20.2PCNA, BIRC5, CLU, PARP1, BCL2, BCL2L1
42sodium orthovanadate32 20.1SETD2, VCL, RAF1, BLZF1, BCR, JAK2
43dehydroepiandrosterone sulfate32 20.1COG2, RBP4, SERPINA6, PAX5, LEP, CGA
44imidazole32 19.1PDE4A, SGCB, CHEK1, MTR, FGF2, MB
45triptolide32 18.7VEGFA, BIRC3, PARP1, BCL2, BAX, JUN
46aphidicolin32 18.6PCNA, RB1, BRCA1, MYC, RAD51, LIG1
47nicotine32 34 9 9 21.4RB1, BMP2, BIRC5, UGT1A, UGT1A1, UGT1A6
48zoledronic acid32 16.3BMP2, BGLAP, PAX5, PARP1, CD36, MMP9
49p00532 16.3SERPINB5, BRCA1, BIRC5, SCARB1, S100A8, MKI67
50bisindolylmaleimide32 15.5PIK3CB, RAF1, RAC1, BDNF, S100B, CFLAR

GO Terms for genes affiliated with Breast Cancer

Sources:
12Gene Ontology
See all sources

Cellular components related to breast cancer according to GeneDecks:

(show all 16)
idNameGO IDScoreTop Affiliating Genes
1plasma membraneGO:005886171.6PIK3CD, PIP4K2B, PIK3R1, PIP5K1A, PICK1, PIK3C2A
2extracellular regionGO:005576103.0PIP, KL, NDFIP1, NCAM1, REG1A, RETN
3nucleoplasmGO:00565495.9ZNF217, PIN1, COBRA1, RFC1, NCOA1, NCOA2
4nucleolusGO:00573089.6ZNF350, PIP5K1A, PINX1, COASY, COBRA1, KLF5
5extracellular spaceGO:00561586.1KL, RELN, CNTF, KIT, KITLG, VTN
6integral to plasma membraneGO:00588778.3LRP1, KL, NCSTN, RET, SGCB, CNR1
7membraneGO:01602051.9PIK3CG, SH2D3C, NCF4, PDE4A, RECK, REM1
8perinuclear region of cytoplasmGO:04847141.1PICK1, LRAT, NDFIP1, PDE4A, PCSK1, BUB1B
9cell surfaceGO:00998640.1LRP6, NCAM1, SFRP1, PCSK6, BST2, VEGFA
10external side of plasma membraneGO:00989728.1NCAM1, KIT, VWF, BTLA, SELP, SERPINA5
11transcription factor complexGO:00566727.2KLF4, NCOA6, RELA, RBL2, NAA15, LMO4
12extracellular matrixGO:03101222.5VWF, VTN, SFRP1, SFRP2, PCSK6, SERPINE2
13membrane raftGO:04512121.1SELE, BSG, BST2, RAB5A, LCK, ATP2B2
14cytoplasmGO:005737INFZNF703, PIAS3, PIP5K1A, PICK1, PIK3C2A, PIK3CG
15nucleusGO:005634INFZNF331, ZNF703, ZNF577, ZNF276, ZNF350, ZNF668
16cytosolGO:005829INFPIK3CB, PIK3CD, PIP4K2B, PIK3CA, PIK3R3, PINK1

Biological processes related to breast cancer according to GeneDecks:

(show top 50)    (show all 97)
idNameGO IDScoreTop Affiliating Genes
1small molecule metabolic processGO:04428187.5PIK3CB, PIK3CD, PIP4K2B, PIK3CA, PIK3R3, PIK3R2
2signal transductionGO:00716583.2PIK3CB, PIK3CD, PIP5K1A, NDFIP1, PDCD1, PDE4A
3positive regulation of cell proliferationGO:00828458.0ZNF703, LRP5, KLF5, REG1A, CNTF, KIT
4negative regulation of cell proliferationGO:00828554.6PINX1, KLF10, KLF11, KLF4, RERG, REST
5blood coagulationGO:00759653.9PIK3CB, PIK3CA, PIK3R3, PIK3R2, PIK3R1, PIK3CG
6cell proliferationGO:00828345.2KLF10, KIF15, KITLG, KIF2C, SFN, PCNA
7cell adhesionGO:00715540.9NCAM1, RELN, CNTNAP1, CNTNAP4, KITLG, VWF
8DNA repairGO:00628140.1RFC1, NCOA6, RECQL4, KIN, KIF22, PCNA
9innate immune responseGO:04508736.8PIK3CD, PIK3R4, PIK3CG, PIN1, NCF2, RELA
10cell divisionGO:05130132.0NDC80, NCAPD2, SGOL1, CNTRL, KIF2C, KIF2A
11platelet activationGO:03016831.8PIK3CB, PIK3CA, PIK3R3, PIK3R2, PIK3R1, PIK3CG
12cytokine-mediated signaling pathwayGO:01922131.4PIN1, KLF6, NCAM1, RELA, KIT, VCAM1
13transcription initiation from RNA polymerase II promoterGO:00636730.8NCOA6, NCOR1, NCOR2, RBPJ, RBL1, SERPINE1
14G-protein coupled receptor signaling pathwayGO:00718628.5PIK3CB, PIK3CG, KISS1, VIP, VIPR1, LPAR1
15positive regulation of cell migrationGO:03033527.7ZNF703, RET, VEGFA, MYLK, BMP2, KDR
16cell cycle arrestGO:00705027.1RB1, NBN, MYC, RASSF1, KHDRBS1, PA2G4
17response to lipopolysaccharideGO:03249627.1NCF2, CNR1, CNR2, PCSK1, SELE, SELP
18response to DNA damage stimulusGO:00697427.0NCOA6, SGK1, KIN, BTG2, RBBP5, BRCA1
19G1/S transition of mitotic cell cycleGO:00008226.8PCNA, RB1, BCL2, CKS1B, UBB, UBC
20insulin receptor signaling pathwayGO:00828626.6PIK3CB, PIK3CA, PIK3R3, PIK3R2, PIK3R4, PIK3R1
21cell surface receptor signaling pathwayGO:00716626.6PIP4K2B, BSG, LIFR, BIRC2, BIRC3, KHDRBS1
22transforming growth factor beta receptor signaling pathwayGO:00717925.9KLF10, NCOR1, NCOR2, RBL1, SERPINE1, MYC
23negative regulation of cell growthGO:03030825.3RERG, SFRP1, SFRP2, BTG1, RB1, RBBP7
24cell cycle checkpointGO:00007525.0BUB1B, BUB3, RB1, RBBP8, RAD17, RAD9A
25response to estradiol stimulusGO:03235524.8NCOA1, GC, SERPINA1, BRCA2, VDR, BMP4
26epidermal growth factor receptor signaling pathwayGO:00717324.0PIK3CA, PIK3R1, PIK3C2A, REPS2, KIF16B, RAF1
27positive regulation of NF-kappaB transcription factor activityGO:05109223.6RELA, RBCK1, CLU, CHUK, UBB, UBC
28fibroblast growth factor receptor signaling pathwayGO:00854323.1PIK3CA, PIK3R1, KL, KIF16B, BRAF, RAF1
29Toll signaling pathwayGO:00806322.4RELA, CHUK, UBB, UBC, UBE2N, ATF1
30positive regulation of angiogenesisGO:04576622.3SFRP2, BTG1, SERPINE1, VEGFA, UTS2, KDR
31response to ethanolGO:04547122.3CNR1, RBP4, BGLAP, BCL2, SDF4, LCT
32induction of apoptosis by extracellular signalsGO:00862422.2NCSTN, VDR, VAV1, VAV2, VAV3, RAC1
33positive regulation of protein phosphorylationGO:00193422.1PIN1, RB1CC1, VEGFA, BMP2, BMP4, MUSK
34positive regulation of ERK1 and ERK2 cascadeGO:07037421.9BRAF, VEGFB, BMP2, BMP4, KDR, CHI3L1
35negative regulation of neuron apoptotic processGO:04352421.9CNTF, NAIP, BRAF, VEGFB, RASA1, LIG4
36toll-like receptor signaling pathwayGO:00222421.8RELA, CHUK, UBB, UBC, UBE2N, ATF1
37toll-like receptor 3 signaling pathwayGO:03413821.7RELA, CHUK, UBB, UBC, ATF1, ATF2
38MyD88-dependent toll-like receptor signaling pathwayGO:00275521.5RELA, CHUK, UBB, UBC, UBE2N, ATF1
39MyD88-independent toll-like receptor signaling pathwayGO:00275621.3RELA, CHUK, UBB, UBC, ATF1, ATF2
40toll-like receptor 1 signaling pathwayGO:03413021.1RELA, CHUK, UBB, UBC, UBE2N, ATF1
41toll-like receptor 2 signaling pathwayGO:03413421.1RELA, CHUK, UBB, UBC, UBE2N, ATF1
42platelet degranulationGO:00257620.7VWF, SELP, SERPINA1, SERPINE1, VEGFA, VEGFB
43cellular response to hypoxiaGO:07145620.5SFRP1, RBX1, VHL, VEGFA, BNIP3, BMP7
44negative regulation of cysteine-type endopeptidase activity involved in apoptotic processGO:04315420.5KLF4, SFN, SFRP2, SERPINB9, NAIP, VEGFA
45positive regulation of protein kinase B signaling cascadeGO:05189720.1PIK3CG, VEGFB, CHI3L1, BAG4, MTDH, MTOR
46positive regulation of MAPK cascadeGO:04341020.0CNTF, KIT, LPAR1, LIF, KDR, LEP
47response to estrogen stimulusGO:04362719.9ZNF366, RBBP5, SERPINE1, BRCA1, BGLAP, BCL2
48stress-activated MAPK cascadeGO:05140319.0UBB, UBC, ATF1, ATF2, JUN, CDK1
49cell cycleGO:007049INFPIN1, NDC80, BUB1B, RB1CC1, SEPT1, SEPT9
50protein phosphorylationGO:006468INFPIK3CD, PINK1, PIK3R4, PICK1, RET, SGK1

Molecular functions related to breast cancer according to GeneDecks:

(show all 22)
idNameGO IDScoreTop Affiliating Genes
1sequence-specific DNA binding transcription factor activityGO:00370068.2ZNF217, KLF10, KLF11, KLF17, KLF4, KLF5
2protein homodimerization activityGO:04280355.1LRP6, NCOA6, KIT, VWF, RCHY1, SETMAR
3sequence-specific DNA bindingGO:04356547.0NANOG, VDR, MYC, RARG, RAG1, RARA
4identical protein bindingGO:04280236.2PICK1, RELA, SFRP1, PCBD1, PCNA, PCM1
5receptor bindingGO:00510235.0PICK1, LRP6, NCK1, CNTNAP1, CNTNAP4, RCHY1
6transcription factor bindingGO:00813435.0RELA, REST, RB1, RBL1, NBN, VHL
7protein heterodimerization activityGO:04698234.9BRAF, VEGFA, VEGFB, BOK, BNIP3, MYC
8enzyme bindingGO:01989934.7PIAS3, PICK1, NCOA1, NCOA6, KIAA1967, BTG1
9chromatin bindingGO:00368232.3RFX4, NCOA1, NCOA2, NCOA3, NCOA6, RELA
10growth factor activityGO:00808331.5REG1A, CNTF, KITLG, BTC, VGF, VEGFA
11transcription coactivator activityGO:00371331.4NCOA1, NCOA2, NCOA3, NCOA4, NCOA6, PCBD1
12protein kinase activityGO:00467229.3PIK3R4, PIK3CG, BUB1, BUB1B, BRAF, RAF1
13transcription regulatory region DNA bindingGO:04421229.3ZNF217, KLF11, KLF17, KLF4, NCOR1, RELA
14signal transducer activityGO:00487128.7KL, NDFIP1, NCOA1, NCOA2, NCOA3, PDCD1
15cytokine activityGO:00512527.4CNTF, KITLG, SECTM1, VEGFA, BMP1, BMP10
16ubiquitin protein ligase bindingGO:03162524.7PINK1, RELA, RB1, RBX1, BRCA1, RAD18
17protein tyrosine kinase activityGO:00471321.0RET, KIT, LMTK2, LMTK3, BMX, KDR
18hormone activityGO:00517920.5KL, RETN, VIP, UTS2, LHB, SCT
19protein serine/threonine kinase activityGO:004674INFPIK3CA, PINK1, PIK3R4, PIK3CG, SGK1, VRK2
20protein kinase bindingGO:019901INFRELA, KIF11, RB1CC1, VIM, RAD9A, RACGAP1
21ATP bindingGO:005524INFPIK3CB, PIK3CD, PIP4K2B, PIK3CA, PINK1, PIP5K1C
22protein bindingGO:005515INFZNF703, ZNF365, ZNF350, ZNF217, ZNF366, PIK3CB

Sources for Breast Cancer

2CDC
11FMA
18HMDB
19ICD9CM
20KEGG
24MeSH
25MGI
27NCIt
28NDF-RT
31NINDS
32Novoseek
33OMIM
35PubMed
36QIAGEN
43UMLS